Company intelligence / Profile preview

Haymann Laboratories

Borehamwood, Hertfordshire, United Kingdom

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Haymann Laboratories is a specialty pharmaceutical company headquartered in the United Kingdom, dedicated to the development and supply of generic and branded medicinal products. The company maintains a diverse portfolio that spans multiple therapeutic categories, including dermatology, respiratory, cardiovascular, and pain management. Haymann focuses on providing high-quality, cost-effective alternatives to off-patent medications, serving both the National Health Service (NHS) and international markets. Their operations encompass the full product lifecycle from formulation development to global distribution and regulatory compliance.

Therapeutic areas: CardiovascularNeurologyDermatologyPulmonologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Haymann Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haymann Laboratories.

Explore the full profile